Urothelial Bladder Carcinomas with High Tumor Mutation Burden Have a Better Prognosis and Targetable Molecular Defects beyond Immunotherapies

Overview of attention for article published in Current Oncology, February 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 27 Mendeley

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 2,072 followers.

⭐️Highly-cited Article Urothelial Bladder Carcinomas with High Tumor Mutation Burden Have a Better Prognosis and Targetable Molecular Defects beyond Immunotherapies by Ioannis A. Voutsadakis ➡️https://t.co/Wjk0QFiSRP #immunotherapy #bladdercancer https…

🆕Article: Urothelial Bladder Carcinomas with High Tumor Mutation Burden Have a Better Prognosis and Targetable Molecular Defects beyond Immunotherapies by Ioannis A. Voutsadakis ➡️https://t.co/Wjk0QFAtJn #bladdercancer #immunotherapy https://t.co/213Zl0…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.